Onconova Therapeutics Probability of Future Stock Price Finishing Over 1.02
| ONTXDelisted Stock | USD 1.02 0.04 3.77% |
Onconova |
Onconova Therapeutics Target Price Odds to finish over 1.02
The tendency of Onconova Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.02 | 90 days | 1.02 | about 88.14 |
Based on a normal probability distribution, the odds of Onconova Therapeutics to move above the current price in 90 days from now is about 88.14 (This Onconova Therapeutics probability density function shows the probability of Onconova Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Onconova Therapeutics has the beta coefficient that is very close to zero. This indicates the returns on DOW JONES INDUSTRIAL and Onconova Therapeutics do not appear to be sensitive. Additionally It does not look like Onconova Therapeutics' alpha can have any bearing on the current valuation. Onconova Therapeutics Price Density |
| Price |
Predictive Modules for Onconova Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Onconova Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Onconova Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Onconova Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Onconova Therapeutics is not an exception. The market had few large corrections towards the Onconova Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Onconova Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Onconova Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | 0.08 |
Onconova Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Onconova Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Onconova Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Onconova Therapeutics is now traded under the symbol TRAW. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Onconova Therapeutics is not yet fully synchronised with the market data | |
| Onconova Therapeutics has some characteristics of a very speculative penny stock | |
| Onconova Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 226 B. Net Loss for the year was (18.95 T) with profit before overhead, payroll, taxes, and interest of 226 K. | |
| Onconova Therapeutics currently holds about 46.53 M in cash with (17.93 T) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Onconova Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Onconova Stock often depends not only on the future outlook of the current and potential Onconova Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Onconova Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21 T | |
| Cash And Short Term Investments | 20.8 T |
Onconova Therapeutics Technical Analysis
Onconova Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Onconova Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Onconova Therapeutics. In general, you should focus on analyzing Onconova Stock price patterns and their correlations with different microeconomic environments and drivers.
Onconova Therapeutics Predictive Forecast Models
Onconova Therapeutics' time-series forecasting models is one of many Onconova Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Onconova Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Onconova Therapeutics
Checking the ongoing alerts about Onconova Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Onconova Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Onconova Therapeutics is now traded under the symbol TRAW. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Onconova Therapeutics is not yet fully synchronised with the market data | |
| Onconova Therapeutics has some characteristics of a very speculative penny stock | |
| Onconova Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 226 B. Net Loss for the year was (18.95 T) with profit before overhead, payroll, taxes, and interest of 226 K. | |
| Onconova Therapeutics currently holds about 46.53 M in cash with (17.93 T) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |